GlassScriptPhysician profile
Jeffrey A Best
NPI 1598833683
$4,731.13
in general payments reported to CMS, 2019-2025
18 companies · $467 in 2025
The $467 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $406 · 2020: $662 · 2021: $625 · 2022: $1,174 · 2023: $1,028 · 2024: $368 · 2025: $467.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,864.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,863.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $1,872.70 | 2019-2025 | Cygnus Dual, Puraply, Simplimax |
| Smith+Nephew, INC. | $1,364.10 | 2019-2025 | Collagenase Santyl, Regranex, Renasys Touch |
| Averitas Pharma INC. | $289.55 | 2023-2024 | Qutenza |
| Grt US Holding, INC. | $275.77 | 2022 | |
| Paratek Pharmaceuticals, INC. | $262.12 | 2023-2025 | Nuzyra |
| Epsfl, LLC | $262.06 | 2023 | |
| Next Science LLC | $90.46 | 2023-2024 | Surgx, Blastx, Xperience |
| Bioventus LLC | $54.33 | 2023-2025 | Exogen Ultrasound Bone Healing System |
| Solventum Corporation | $47.96 | 2024-2025 | Promogran Prisma, Activ.A.C. |
| Kowa Pharmaceuticals America, INC. | $45.84 | 2022 | |
| Integra Lifesciences Corporation | $42.43 | 2024-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Abbvie INC. | $25.20 | 2023 | Dalvance |
| Tactile Systems Technology INC | $20.47 | 2025 | Flexitouch Plus, Nimbl |
| Convatec INC. | $19.44 | 2023 | |
| Celularity INC. | $17.00 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $15.56 | 2023 | Tegaderm, V.A.C. Dermatac, Activ.A.C. |
| Urgo Medical North America, LLC | $15.13 | 2025 | Urgoclean Ag |
| Nabriva Therapeutics, Plc | $11.01 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Best listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.